In January 2020, Corin received results from the 2019 ODEP Hip products review. Below are the updated ratings and some information to explain ODEP ratings.
Trinity™ with ECiMa liner = 7A*
Our flagship product, with over 125,000 implantations worldwide, has now secured its place in the market as one of the best cementless cups available. Our existing customers can continue to implant with confidence and new customers can be encouraged by a history of excellent performance and outstanding results.
MetaFix™ collarless = 10A
MetaFix™ collared = 3A
Based on one of the world’s biggest selling uncemented hip philosophies, MetaFix™ now has over 47,500 implantations worldwide. MetaFix™ stem offers our customers a reliable stem philosophy.
TriFit TS™ = 5A
The latest Corin femoral stem launched with more than 25,000 implantations worldwide to date. The stem geometry is defined by 3D analysis of global CT data to deliver a patient matched solution.
What is ODEP?
ODEP (Orthopaedic Data Evaluation Panel) is an independent panel of experts comprised mainly of leading UK surgeons, but also non-clinical experts with deep experience of the orthopaedic industry. The Panel was set up by National Health Purchasing and Supply Agency (PASA, subsequently replaced by NHS Supply Chain) as a response to National Institute for Health and Care Excellence (NICE) issuing guidance relating to Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (http://www.nice.org.uk/Guidance/TA304) - first publication April 2000, most recent publication in February 2014.
Implant manufacturers are invited to submit data regarding their orthopaedic implant products to ODEP. The panel reviews this submission and rate the strength of the evidence presented by the manufacturer, resulting in the award of an ODEP rating.
ODEP ratings explained
An ODEP rating should simply define a products clinical performance. It fundamentally consists of a NUMBER and a LETTER (and in some cases a STAR).
The number represents the number of years for which the product’s performance has been evidenced. Categories are 3, 5, 7, 10 and 13 years.
The letter represents the strength of evidence (data) presented by the manufacturer:
A* Very strong evidence.
A Strong evidence. Generally higher numbers of patients (giving greater confidence in the results presented), with all patients being subject to follow-up (their outcomes recorded).
B Acceptable evidence. Smaller numbers of patients giving less confidence in the results, but enough data to demonstrate compliance
There are ratings for new products that are registered with ODEP for which there is insufficient data to evidence the three-year entry benchmark but are currently undergoing clinical evaluation.
Pre-entry A* Products are being evaluated through the Beyond Compliance initiative, a post market surveillance service supported by ODEP.
Pre-entry Products not under Beyond Compliance, but which are registered with the National Joint Registry.
For all other ODEP rated Corin products please visit http://www.odep.org.uk/ for the most up to date ratings.
English
French